Brief: SK Chemicals to divest vaccine pharmaceutical business into new subsidiary
May 2 (Reuters) - SK Chemicals Co Ltd 285130.KS :
* Says it plans to divest vaccine pharmaceutical business
into new
wholly owned subsidiary named SK bioscience Co.,Ltd
* Expected divestiture date is July 1
Source text in Korean : https://goo.gl/Ui6jsg
Further company coverage: 285130.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on SK Chemicals
See all newsBrief: Sk Chemicals Co Aims 11% Operating Margin By 2030
Brief: Sk Chemicals Co Q1 Consolidated Operating. Loss 18.9 Billion Won Versus 24.3 Billion Won Profit A Year Ago
Brief: Sk Chemicals Sells 220 Billion Won Exchangeable Bonds
Brief: SK Chemicals Partners with Durmont to Supply Sustainable Materials to Global Auto Brands
South Korea's mountain of plastic waste shows limits of recycling (updated)